SS Innovations International (NASDAQ:SSII) Trading Down 7.4% – Here’s What Happened

Posted by Brian Himes on Jun 4th, 2026

SS Innovations International, Inc. (NASDAQ:SSII – Get Free Report)’s share price dropped 7.4% during trading on Thursday . The stock traded as low as $3.93 and last traded at $3.99. Approximately 107,155 shares changed hands during mid-day trading, an increase of 40% from the average daily volume of 76,300 shares. The stock had previously closed at $4.31.

Analysts Set New Price Targets

Several brokerages have recently weighed in on SSII. Weiss Ratings restated a “sell (e+)” rating on shares of SS Innovations International in a report on Tuesday, April 21st. Wall Street Zen upgraded shares of SS Innovations International from a “sell” rating to a “hold” rating in a research note on Saturday, May 16th. Finally, Loop Capital set a $7.00 price objective on shares of SS Innovations International in a research note on Wednesday. One investment analyst has rated the stock with a Sell rating, According to MarketBeat, SS Innovations International presently has a consensus rating of “Sell” and a consensus target price of $7.00.

Read Our Latest Stock Report on SS Innovations International

SS Innovations International Trading Down 9.2%

The firm has a 50 day simple moving average of $4.36 and a 200 day simple moving average of $4.93. The firm has a market capitalization of $783.51 million, a PE ratio of -78.20 and a beta of -1.88.

SS Innovations International (NASDAQ:SSII – Get Free Report) last posted its quarterly earnings results on Wednesday, May 13th. The company reported ($0.02) earnings per share for the quarter. SS Innovations International had a negative return on equity of 23.00% and a negative net margin of 20.69%.The business had revenue of $11.10 million during the quarter.

Insider Buying and Selling at SS Innovations International

In related news, CEO Srivastava Sudhir bought 498,753 shares of the stock in a transaction on Friday, March 6th. The shares were acquired at an average price of $4.01 per share, for a total transaction of $1,999,999.53. Following the purchase, the chief executive officer owned 109,851,767 shares of the company’s stock, valued at approximately $440,505,585.67. The trade was a 0.46% increase in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Also, Director Timothy P. Adams purchased 300,000 shares of SS Innovations International stock in a transaction dated Friday, March 6th. The stock was bought at an average price of $3.99 per share, with a total value of $1,197,000.00. Following the completion of the purchase, the director directly owned 5,331,902 shares of the company’s stock, valued at approximately $21,274,288.98. This trade represents a 5.96% increase in their ownership of the stock. Additional details regarding this purchase are available in the official SEC disclosure. In the last 90 days, insiders have purchased 1,300,006 shares of company stock worth $5,196,999.

Institutional Trading of SS Innovations International

A number of hedge funds have recently bought and sold shares of the company. Handelsbanken Fonder AB purchased a new stake in shares of SS Innovations International during the 3rd quarter valued at about $714,000. Inspire Investing LLC raised its position in shares of SS Innovations International by 124.4% during the 4th quarter. Inspire Investing LLC now owns 82,773 shares of the company’s stock valued at $470,000 after purchasing an additional 45,886 shares during the period. Vontobel Holding Ltd. bought a new stake in shares of SS Innovations International during the 4th quarter valued at $116,000. Envestnet Asset Management Inc. purchased a new position in shares of SS Innovations International during the 3rd quarter valued at $71,000. Finally, Goldman Sachs Group Inc. bought a new position in SS Innovations International in the 4th quarter worth $68,000.

SS Innovations International Company Profile

(Get Free Report)

AVRA Medical Robotics, Inc develops and manufactures medical surgical devices. The company has a research agreement with the University of Central Florida to develop navigation and control technologies with applications in medical robotics. The company was formerly known as AVRA Surgical Microsystems, Inc and changed its name to AVRA Medical Robotics, Inc in November 2015. AVRA Medical Robotics, Inc was founded in 2015 and is based in Orlando, Florida.